Brendan Teehan

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Brisbane, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Kristen Williams, Attorney-in-Fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Brendan Teehan

Form 4 holding EVP, COO, HEAD OF COMMERCIAL

ACADIA PHARMACEUTICALS INC

Security class
Common Stock
Shares / value
62,105
Estimated value
$1,043,985
Report date
19 Nov 2024
Price
$16.81
Ownership
Direct
Form 4 holding EVP, COO, HEAD OF COMMERCIAL

ACADIA PHARMACEUTICALS INC

Security class
Restricted Stock Units
Shares / value
9,913
Estimated value
$166,638
Report date
17 Nov 2024
Price
$16.81
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding EVP, COO, HEAD OF COMMERCIAL

ACADIA PHARMACEUTICALS INC

Security class
Stock Options (Right to Buy)
Shares / value
89,516
Estimated value
Report date
25 Mar 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Brendan Teehan

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .